E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma

被引:42
|
作者
Saito, T
Oda, Y
Kawaguchi, K
Sugimachi, K
Yamamoto, H
Tateishi, N
Tanaka, K
Matsuda, S
Iwamoto, Y
Ladanyi, M
Tsuneyoshi, M
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka 8128582, Japan
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
E-cadherin; Snail; CpG methylation; mutation; ELF3; synovial sarcoma; epithelial-mesenchymal transition;
D O I
10.1038/sj.onc.1207960
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have recently reported frequent E-cadherin gene mutations in synovial sarcoma (SS), suggesting mutational inactivation of E-cadherin as a potential mechanism of spindle cell morphology in SS, a spindle cell sarcoma that shows areas of glandular epithelial differentiaton in some cases (biphasic SS) and only pure spindle cell morphology in most cases (monophasic SS). However, the mechanism of downregulation of E-cadherin in SS remains unknown. To further address this issue, we analysed the mechanisms of E-cadherin silencing in 40 SS. Genetic and epigenetic changes in the E-cadherin gene, and the expression level of its transcriptional repressor Snail were examined by polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP), methylation-specific PCR, and real-time quantitative PCR, respectively. Expression of E-cadherin was examined by RT-PCR and immunohistochemistry. We also examined ELF3, a transcription factor associated with epithelial differentiation in SS in a previous cDNA microarray, by RT-PCR. E-cadherin and ELF3 transcripts were detected, respectively, in 27/40 (67.5%) and in 25/40 (62.5%) of SS, and these epithelial-related genes were almost always coexpressed. Hypermethylation of the promoter of the E-cadherin gene was detected in five cases (12.5%) in SS; however, E-cadherin was silenced at mRNA level in only one of the five cases. E-cadherin missense mutations were observed in five cases (12.5%) of SS. In SS, all five cases with E-cadherin missense mutations had the SYT-SSX1 fusion and were monophasic tumors, suggesting a relationship between the SYT-SSX fusion type and E-cadherin missense mutation (P = 0.07). E-cadherin mRNA expression in SS was associated with reduced Snail expression level (P = 0.03). E-cadherin membranous expression was observed in 14/40 (35.0%) of SS, and was also correlated with SYT-SSX1 fusion type and biphasic histology. ELF3 was confirmed to be more highly expressed in biphasic than monophasic SS by real-time quantitative PCR. These results suggest that in SS the loss of E-cadherin expression occurs either by Snail trans-repression or by inactivating mutations. Thus, E-cadherin downregulation is associated with the loss or absence of glandular epithelial differentiation in certain SS.
引用
收藏
页码:8629 / 8638
页数:10
相关论文
共 50 条
  • [41] E-cadherin signaling in prostate cancer
    Chunthapong, J
    Seftor, E
    Khalkhali-Ellis, Z
    Sullivan, CM
    Hendrix, MJC
    Heidger, PM
    FASEB JOURNAL, 2003, 17 (05): : A1175 - A1175
  • [42] E-cadherin mutations in gastric carcinoma
    Machado, JC
    Carneiro, F
    Sobrinho-Simoes, M
    JOURNAL OF PATHOLOGY, 2000, 191 (04): : 466 - 467
  • [43] E-Cadherin Radial Distribution Characterization for Mutation Detection Purposes
    Esmenio, Sofia
    Figueiredo, Joana
    Seruca, Raquel
    Miguel Sanches, J.
    PATTERN RECOGNITION AND IMAGE ANALYSIS, IBPRIA 2013, 2013, 7887 : 173 - 180
  • [44] E-cadherin expression in ovarian carcinoma
    Nature Clinical Practice Oncology, 2005, 2 (1): : 6 - 6
  • [45] E-cadherin deregulation in breast cancer
    Corso, Giovanni
    Figueiredo, Joana
    De Angelis, Simone Pietro
    Corso, Federica
    Girardi, Antonia
    Pereira, Joana
    Seruca, Raquel
    Bonanni, Bernardo
    Carneiro, Patricia
    Pravettoni, Gabriella
    Guerini Rocco, Elena
    Veronesi, Paolo
    Montagna, Giacomo
    Sacchini, Virgilio
    Gandini, Sara
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (11) : 5930 - 5936
  • [46] E-Cadherin expression in malignant melanomas
    Silye, R
    Pignatelli, M
    Regele, H
    Boesmueller, H
    Sega, W
    Krausz, T
    JOURNAL OF PATHOLOGY, 1996, 179 : A30 - A30
  • [47] E-cadherin in contact inhibition and cancer
    Alisha M. Mendonsa
    Tae-Young Na
    Barry M. Gumbiner
    Oncogene, 2018, 37 : 4769 - 4780
  • [48] Regulation of E-cadherin cleavages in keratinocytes
    Kee, SH
    Steinert, PM
    Jang, SI
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 348A - 348A
  • [49] E-cadherin in head and neck cancer
    Yoda, J
    Hirohashi, Y
    Yamanaka, N
    SYDNEY '97 - XVI WORLD CONGRESS OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY, TOMES 1 AND 2, 1996, : 403 - 406
  • [50] E-cadherin expression in DCIS of the breast
    Gupta, SK
    DouglasJones, AG
    Morgan, JM
    Pignatelli, M
    Mansel, RE
    Jasani, B
    JOURNAL OF PATHOLOGY, 1997, 181 : A23 - A23